| Subscribe to access full data | ||||||
|---|---|---|---|---|---|---|
| Company | Business Sector | Market cap ($) | # net buying insiders | Net value bought ($) | % of float bought | % of shares held by insiders |
|
|
Pharmaceuticals & Medical Research | Nano (11.7mn) | 0 | No activity | — | 15–50% |
|
|
Healthcare Services | Nano (11.7mn) | 0 | No activity | — | 15–50% |
| Pharmaceuticals & Medical Research | Nano (11.7mn) | 1–5 | < $100K | 0–15% | 0–15% | |
|
|
Pharmaceuticals & Medical Research | Nano (11.6mn) | 0 | No activity | — | 0–15% |
|
|
Pharmaceuticals & Medical Research | Nano (11.6mn) | 0 | No activity | — | 15–50% |
|
|
Healthcare Services | Nano (11.4mn) | 1–5 | < $100K | 0–15% | 15–50% |
|
|
Pharmaceuticals & Medical Research | Nano (11.4mn) | 0 | No activity | — | 15–50% |
|
|
Pharmaceuticals & Medical Research | Nano (11.3mn) | 0 | No activity | — | 0–15% |
|
|
Pharmaceuticals & Medical Research | Nano (11.3mn) | 0 | -$100K–$1M | -0–15% | 15–50% |
|
|
Pharmaceuticals & Medical Research | Nano (11.3mn) | 0 | No activity | — | 50%+ |
| Pharmaceuticals & Medical Research | Nano (11.3mn) | 0 | No activity | — | 50%+ | |
|
|
Pharmaceuticals & Medical Research | Nano (11.3mn) | 1–5 | < $100K | 0–15% | 0–15% |
|
|
Healthcare Services | Nano (11.1mn) | 0 | No activity | — | 50%+ |
|
|
Pharmaceuticals & Medical Research | Nano (11.0mn) | 0 | No activity | — | 15–50% |
|
|
Pharmaceuticals & Medical Research | Nano (11.0mn) | 0 | No activity | — | 0–15% |
| Pharmaceuticals & Medical Research | Nano (11.0mn) | 0 | No activity | — | 15–50% | |
| Healthcare Services | Nano (11.0mn) | 0 | No activity | — | 15–50% | |
|
|
Pharmaceuticals & Medical Research | Nano (11.0mn) | 1–5 | < $100K | 0–15% | — |
|
|
Healthcare Services | Nano (11.0mn) | 0 | No activity | — | 15–50% |
|
|
Pharmaceuticals & Medical Research | Nano (10.9mn) | 0 | No activity | — | 50%+ |
| Pharmaceuticals & Medical Research | Nano (10.9mn) | 0 | No activity | — | — | |
|
|
Pharmaceuticals & Medical Research | Nano (10.8mn) | 0 | No activity | — | 15–50% |
|
|
Pharmaceuticals & Medical Research | Nano (10.8mn) | 0 | No activity | — | 15–50% |
|
|
Pharmaceuticals & Medical Research | Nano (10.8mn) | 1–5 | $100K–$1M | 0–15% | 15–50% |
|
|
Healthcare Services | Nano (10.7mn) | 0 | No activity | — | 15–50% |
|
|
Healthcare Services | Nano (10.6mn) | 0 | No activity | — | 0–15% |
| Pharmaceuticals & Medical Research | Nano (10.6mn) | 0 | No activity | — | 50%+ | |
|
|
Healthcare Services | Nano (10.6mn) | 0 | No activity | — | 0–15% |
|
|
Healthcare Services | Nano (10.6mn) | 0 | No activity | — | 15–50% |
| Pharmaceuticals & Medical Research | Nano (10.5mn) | -1–5 | -$1M–$10M | -15–50% | 15–50% | |
|
|
Pharmaceuticals & Medical Research | Nano (10.4mn) | 0 | No activity | — | 0–15% |
| Healthcare Services | Nano (10.4mn) | 0 | No activity | — | 0–15% | |
|
|
Healthcare Services | Nano (10.4mn) | 0 | No activity | — | 50%+ |
|
|
Pharmaceuticals & Medical Research | Nano (10.3mn) | 0 | No activity | — | 15–50% |
|
|
Pharmaceuticals & Medical Research | Nano (10.3mn) | 0 | < $100K | 0–15% | 15–50% |
|
|
Pharmaceuticals & Medical Research | Nano (10.2mn) | 0 | No activity | — | 0–15% |
|
|
Healthcare Services | Nano (10.2mn) | 0 | No activity | — | 0–15% |
|
|
Pharmaceuticals & Medical Research | Nano (10.1mn) | 0 | No activity | — | 15–50% |
|
|
Pharmaceuticals & Medical Research | Nano (10.1mn) | 0 | No activity | — | 0–15% |
|
|
Healthcare Services | Nano (9.9mn) | 0 | No activity | — | 15–50% |
| Pharmaceuticals & Medical Research | Nano (9.7mn) | 0 | No activity | — | 15–50% | |
|
|
Healthcare Services | Nano (9.7mn) | 1–5 | $100K–$1M | 0–15% | 15–50% |
|
|
Pharmaceuticals & Medical Research | Nano (9.7mn) | 0 | No activity | — | 0–15% |
|
|
Healthcare Services | Nano (9.6mn) | 0 | No activity | — | 0–15% |
|
|
Pharmaceuticals & Medical Research | Nano (9.5mn) | 0 | No activity | — | 0–15% |
|
|
Pharmaceuticals & Medical Research | Nano (9.5mn) | 0 | No activity | — | 15–50% |
|
|
Pharmaceuticals & Medical Research | Nano (9.5mn) | 0 | No activity | — | 0–15% |
|
|
Pharmaceuticals & Medical Research | Nano (9.5mn) | -1–5 | -< $100K | -50%+ | 0–15% |
|
|
Healthcare Services | Nano (9.4mn) | 0 | No activity | — | 15–50% |
|
|
Pharmaceuticals & Medical Research | Nano (9.4mn) | 0 | No activity | — | 15–50% |
|
|
Healthcare Services | Nano (9.4mn) | 0 | No activity | — | 15–50% |
|
|
Healthcare Services | Nano (9.4mn) | 0 | No activity | — | 0–15% |
|
|
Pharmaceuticals & Medical Research | Nano (9.2mn) | 0 | No activity | — | 50%+ |
|
|
Pharmaceuticals & Medical Research | Nano (9.2mn) | 0 | No activity | — | 0–15% |
|
|
Pharmaceuticals & Medical Research | Nano (9.2mn) | 1–5 | < $100K | 0–15% | 15–50% |
|
|
Pharmaceuticals & Medical Research | Nano (9.2mn) | 0 | No activity | — | 0–15% |
|
|
Healthcare Services | Nano (9.2mn) | 0 | No activity | — | 50%+ |
|
|
Pharmaceuticals & Medical Research | Nano (9.2mn) | 0 | No activity | — | 0–15% |
|
|
Healthcare Services | Nano (9.1mn) | 0 | No activity | — | — |
| Pharmaceuticals & Medical Research | Nano (9.1mn) | 0 | No activity | — | 50%+ | |
|
|
Healthcare Services | Nano (9.0mn) | 0 | No activity | — | 15–50% |
|
|
Pharmaceuticals & Medical Research | Nano (9.0mn) | 1–5 | $100K–$1M | 0–15% | 0–15% |
|
|
Pharmaceuticals & Medical Research | Nano (8.9mn) | 0 | No activity | — | 50%+ |
|
|
Healthcare Services | Nano (8.8mn) | 0 | No activity | — | 50%+ |
|
|
Healthcare Services | Nano (8.8mn) | 0 | No activity | — | 0–15% |
|
|
Pharmaceuticals & Medical Research | Nano (8.7mn) | 0 | No activity | — | — |
|
|
Pharmaceuticals & Medical Research | Nano (8.5mn) | 1–5 | < $100K | 0–15% | 0–15% |
|
|
Healthcare Services | Nano (8.4mn) | 0 | No activity | — | 0–15% |
|
|
Healthcare Services | Nano (8.4mn) | 0 | No activity | — | 0–15% |
|
|
Pharmaceuticals & Medical Research | Nano (8.3mn) | 0 | No activity | — | 0–15% |
|
|
Pharmaceuticals & Medical Research | Nano (8.3mn) | 0 | No activity | — | 15–50% |
|
|
Pharmaceuticals & Medical Research | Nano (8.3mn) | 0 | No activity | — | 15–50% |
|
|
Pharmaceuticals & Medical Research | Nano (8.3mn) | 1–5 | < $100K | 0–15% | 0–15% |
|
|
Pharmaceuticals & Medical Research | Nano (8.3mn) | 0 | No activity | — | 0–15% |
|
|
Healthcare Services | Nano (8.3mn) | 0 | No activity | — | 15–50% |
|
|
Healthcare Services | Nano (8.2mn) | 1–5 | < $100K | 0–15% | 50%+ |
|
|
Pharmaceuticals & Medical Research | Nano (8.2mn) | 0 | No activity | — | 0–15% |
|
|
Pharmaceuticals & Medical Research | Nano (8.2mn) | 0 | No activity | — | 0–15% |
|
|
Pharmaceuticals & Medical Research | Nano (8.2mn) | 0 | No activity | — | 0–15% |
|
|
Pharmaceuticals & Medical Research | Nano (8.1mn) | 0 | No activity | — | 0–15% |
|
|
Healthcare Services | Nano (8.1mn) | 0 | No activity | — | 0–15% |
|
|
Pharmaceuticals & Medical Research | Nano (8.0mn) | 0 | No activity | — | 15–50% |
|
|
Healthcare Services | Nano (7.9mn) | 0 | No activity | — | — |
|
|
Pharmaceuticals & Medical Research | Nano (7.8mn) | 0 | No activity | — | 15–50% |
|
|
Pharmaceuticals & Medical Research | Nano (7.8mn) | 0 | No activity | — | 50%+ |
| Pharmaceuticals & Medical Research | Nano (7.6mn) | 0 | No activity | — | 50%+ | |
|
|
Pharmaceuticals & Medical Research | Nano (7.6mn) | 0 | No activity | — | 15–50% |
| Pharmaceuticals & Medical Research | Nano (7.6mn) | 0 | No activity | — | 0–15% | |
|
|
Pharmaceuticals & Medical Research | Nano (7.5mn) | 0 | No activity | — | 15–50% |
|
|
Pharmaceuticals & Medical Research | Nano (7.4mn) | 0 | No activity | — | 0–15% |
|
|
Healthcare Services | Nano (7.4mn) | 0 | No activity | — | 15–50% |
|
|
Pharmaceuticals & Medical Research | Nano (7.4mn) | 0 | No activity | — | 0–15% |
|
|
Pharmaceuticals & Medical Research | Nano (7.3mn) | 0 | No activity | — | 50%+ |
|
|
Pharmaceuticals & Medical Research | Nano (7.3mn) | 0 | No activity | — | — |
|
|
Pharmaceuticals & Medical Research | Nano (7.3mn) | 0 | No activity | — | 15–50% |
|
|
Pharmaceuticals & Medical Research | Nano (7.3mn) | 0 | No activity | — | 0–15% |
|
|
Healthcare Services | Nano (7.2mn) | 0 | No activity | — | 15–50% |
|
|
Pharmaceuticals & Medical Research | Nano (7.2mn) | 0 | No activity | — | 0–15% |
|
|
Pharmaceuticals & Medical Research | Nano (7.1mn) | 0 | No activity | — | 0–15% |
|
|
Healthcare Services | Nano (7.1mn) | 0 | No activity | — | 50%+ |